Since 2019, the FDA has reported dozens of drug recalls because of the presence of nitrosamine, a probable carcinogen that largely pulls blood pressure treatments off the market.
Category: ROOT
Top supply leaders' plans for 2023 and 7 more supply chain updates
Here are eight supply chain updates for ASC leaders reported by Becker’s since Dec. 20:
Court OKs medical office building construction following eminent domain battle
Bowers Development will move forward with the construction of a medical office building in Utica, N.Y., following an eminent domain battle with the Oneida County Industrial Development Agency, according to a Dec. 27 report from WKTV.
AHA updates guidelines for diagnosing, treating heart attacks in older adults
The American Heart Association released a new scientific statement Dec. 12 that updates information for diagnosing and treating acute coronary syndrome in people 75 and older.
Men's residence, race determine odds of death by certain cancers
A recent American Cancer Society study found geographic and racial disparities in incidence and mortality rates for men with a major genitourinary cancer.
New Jersey hospital workers reach new deal with county
Healthcare workers at a behavioral health facility in New Jersey have secured pay increases of up to 11 percent over four years as well as freezes on their health premiums, New Jersey news service tapinto.net reported Dec. 28.
HCA, Tenet and others looking for 17 CFOs
Hospitals around the country are seeking CFOs, including several owned by Nashville, Tenn.-based HCA Healthcare, Dallas-based Tenet Healthcare and Franklin, Tenn.-based Community Health Systems.
Here are 17 hospitals with recently-posted CFO openings,…
Walgreens healthcare updates: 16 moves in 60 days
Sixteen Walgreens updates Becker’s has reported on since Oct. 18:
Opus Genetics acquires rights to two therapy products for retinal disease
Opus Genetics, a clinical-stage gene therapy company, has acquired the rights to two preclinical-stage AAV-based gene therapy products from Iveric Bio, a biopharmaceutical company.
OSU students find inequalities in ophthalmology research
Oklahoma State University students at both Tulsa and Tahlequah campuses have found inequalities in ophthalmology research for Indigenous, Asian and LGBTQ patient populations, Fox 23 reported Dec. 25.
